Shaoyuan Zhang

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyPredictive and prognostic markersHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 17, 2026
Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Jan 07, 2026
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Jun 26, 2025
Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials.

Jun Okui, Kengo Nagashima, Satoru Matsuda

|Sep 16, 2023
Telocytes protect against lung tissue fibrosis through hexokinase 2-dependent pathway by secreting hepatocyte growth factor.

Shaoyuan Zhang, Linyi Sun, Borong Chen

|Feb 24, 2023
Association of LAMA1 Single-Nucleotide Polymorphisms with Risk of Esophageal Squamous Cell Carcinoma among the Eastern Chinese Population.

Shaoyuan Zhang, Yong Fang, Feng Su

|Mar 24, 2022
The Single Nucleotide Polymorphisms of AP1S1 are Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Population.

Feng Su, Yong Fang, Jinjie Yu

Pageof 1

Frequent Collaborators

4 joint publications

Lijie Tan

3 joint publications

Ken Kato

3 joint publications

Charlène van der Zijden

3 joint publications

Takahiro Tsushima